{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:02:08Z","timestamp":1787929328594,"version":"build-2784847793"},"reference-count":31,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-DK61212"],"award-info":[{"award-number":["U01-DK61212"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-DK61230"],"award-info":[{"award-number":["U01-DK61230"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-DK61239"],"award-info":[{"award-number":["U01-DK61239"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-DK61242"],"award-info":[{"award-number":["U01-DK61242"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-DK61254"],"award-info":[{"award-number":["U01-DK61254"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>In the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study, an intervention trial followed by an observational phase, half the participants reached the primary outcome [hemoglobin A1c (HbA1c) \u2265 8% for at least 6 months] within 4 years, which was associated with a decrease in C-peptide oral disposition index (oDI). We aimed to identify circulating microRNA (miRNA) species associated with a decline in beta cell function.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Following a preliminary survey of select participants using nCounter Human v3 miRNA Panel (NanoString Technologies), polymerase chain reaction analyses were carried out for 17 miRNAs from 365 participants from samples at baseline, 24, 60, 96, and 120 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Using a backward selection approach, 4 baseline miRNA log2 fold-changes independently predicted treatment failure; however, baseline HbA1c was higher in those with treatment failure. Three baseline miRNA log2 fold-changes remained significant predictors of this C-peptide oDI decline \u226520% (P &amp;lt; .05). Increased levels of miRNA-155 [odds ratio (OR): 1.2, 95% confidence interval (CI): 1.1-1.4] and miRNA-130b (OR:1.3, 95% CI: 1.0-1.7) were associated with oDI decline, while decreased levels of miRNA-126 (OR: 0.6, 95% CI: .4-.8) were associated with oDI decline. miRNA-122 was negatively correlated with C-peptide oDI at baseline and 24 months (R = 0.22, P &amp;lt; .01 and R = 0.19, P &amp;lt; .01, respectively) and positively correlated with proinsulin at baseline, 24, and 60 months (R = 0.26, P &amp;lt; 0.01, R = 0.26, P &amp;lt; .01, R = 0.18, P &amp;lt; .01, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The miRNA species associated with beta cell function are associated with alterations in cellular metabolism and apoptosis, suggesting that differences in baseline abundance may serve as circulating markers of beta cell dysfunction and provide potential mechanistic insights into the aggressive nature of youth-onset type 2 diabetes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae376","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T20:39:53Z","timestamp":1717101593000},"page":"3027-3035","source":"Crossref","is-referenced-by-count":9,"title":["Circulating MicroRNAs as Predictors of Beta Cell Function in Youth-onset Type 2 Diabetes: The TODAY Study"],"prefix":"10.1210","volume":"109","author":[{"given":"Dakota","family":"Redling","sequence":"first","affiliation":[{"name":"University of Oklahoma Health Sciences Center , Oklahoma City, OK 73104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Bialak","sequence":"additional","affiliation":[{"name":"University of Oklahoma Health Sciences Center , Oklahoma City, OK 73104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4223-8407","authenticated-orcid":false,"given":"Laure","family":"El ghormli","sequence":"additional","affiliation":[{"name":"The Biostatistics Center, George Washington University , Rockville, MD 20852 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9927-4460","authenticated-orcid":false,"given":"Steven D","family":"Chernausek","sequence":"additional","affiliation":[{"name":"University of Oklahoma Health Sciences Center , Oklahoma City, OK 73104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Jones","sequence":"additional","affiliation":[{"name":"University of Oklahoma Health Sciences Center , Oklahoma City, OK 73104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5050-0850","authenticated-orcid":false,"given":"Jeanie B","family":"Tryggestad","sequence":"additional","affiliation":[{"name":"University of Oklahoma Health Sciences Center , Oklahoma City, OK 73104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"issue":"4","key":"2024111804001323200_dgae376-B1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S2213-8587(23)00037-2","article-title":"SEARCHing for answers to youth-onset type 2 diabetes","volume":"11","author":"Shaw","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2024111804001323200_dgae376-B2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2337\/dc22-0945","article-title":"Projections of type 1 and type 2 diabetes burden in the U.S. Population aged &lt;20 years through 2060: the SEARCH for diabetes in youth study","volume":"46","author":"Tonnies","year":"2023","journal-title":"Diabetes Care"},{"issue":"24","key":"2024111804001323200_dgae376-B3","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1109333","article-title":"A clinical trial to maintain glycemic control in youth with type 2 diabetes. Multicenter study randomized controlled trial research support, N.I.H., extramural research support, non-U.S. Gov't","volume":"366","author":"Zeitler","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"2024111804001323200_dgae376-B4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa2100165","article-title":"Long-term complications in youth-onset type 2 diabetes","volume":"385","author":"TODAY Study Group","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"2024111804001323200_dgae376-B5","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/dc12-2393","article-title":"Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and beta-cell function in TODAY","volume":"36","author":"TODAY Study Group","year":"2013","journal-title":"Diabetes Care"},{"issue":"11","key":"2024111804001323200_dgae376-B6","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2337\/dc22-0784","article-title":"Long-term outcomes among young adults with type 2 diabetes based on durability of glycemic control: results from the TODAY cohort study","volume":"45","author":"TODAY Study Group","year":"2022","journal-title":"Diabetes Care"},{"key":"2024111804001323200_dgae376-B7","doi-asserted-by":"crossref","first-page":"647864","DOI":"10.3389\/fendo.2021.647864","article-title":"A genetic risk score improves the prediction of type 2 diabetes Mellitus in Mexican youths but has lower predictive utility compared with non-genetic factors","volume":"12","author":"Miranda-Lora","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024111804001323200_dgae376-B8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.freeradbiomed.2013.06.009","article-title":"MicroRNAs: potential mediators and biomarkers of diabetic complications","volume":"64","author":"Kato","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"2024111804001323200_dgae376-B9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11892-016-0812-9","article-title":"Biomarkers of diabetic retinopathy","volume":"16","author":"Ting","year":"2016","journal-title":"Curr Diab Rep"},{"issue":"11","key":"2024111804001323200_dgae376-B10","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.4103\/1673-5374.259602","article-title":"MicroRNAs as biomarkers of diabetic retinopathy and disease progression","volume":"14","author":"Martinez","year":"2019","journal-title":"Neural Regen Res"},{"issue":"12","key":"2024111804001323200_dgae376-B11","doi-asserted-by":"crossref","first-page":"e0188980","DOI":"10.1371\/journal.pone.0188980","article-title":"A unique plasma microRNA profile defines type 2 diabetes progression","volume":"12","author":"de Candia","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"2024111804001323200_dgae376-B12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/2211536603666141118232514","article-title":"Micro RNA: an epigenetic regulator of type 2 diabetes","volume":"3","author":"Kadamkode","year":"2014","journal-title":"Microrna"},{"issue":"8","key":"2024111804001323200_dgae376-B13","doi-asserted-by":"crossref","first-page":"e0182932","DOI":"10.1371\/journal.pone.0182932","article-title":"Identification of novel biomarkers to monitor beta-cell function and enable early detection of type 2 diabetes risk","volume":"12","author":"Belongie","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"2024111804001323200_dgae376-B14","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cmet.2019.07.011","article-title":"Extracellular miRNAs: from biomarkers to mediators of physiology and disease","volume":"30","author":"Mori","year":"2019","journal-title":"Cell Metab"},{"issue":"2","key":"2024111804001323200_dgae376-B15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1399-5448.2007.00237.x","article-title":"Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Comparative study multicenter study randomized controlled trial research support, N.I.H., extramural","volume":"8","author":"Zeitler","year":"2007","journal-title":"Pediatr Diabetes"},{"key":"2024111804001323200_dgae376-B16","doi-asserted-by":"crossref","unstructured":"Redling D, Bialak S, El ghormli L, Chernausek SD, Jones K, Tryggestad JB. Data from: circulating MicroRNAs as predictors of beta cell function in youth onset type 2 diabetes: the TODAY study. 2024. figshare. Deposited April 3, 2024. doi:10.6084\/m9.figshare.25534768","DOI":"10.1210\/clinem\/dgae376"},{"issue":"1","key":"2024111804001323200_dgae376-B17","doi-asserted-by":"crossref","first-page":"14274","DOI":"10.1038\/s41598-018-32274-9","article-title":"Circulating microRNAs -192 and -194 are associated with the presence and incidence of diabetes mellitus","volume":"8","author":"Jaeger","year":"2018","journal-title":"Sci Rep"},{"key":"2024111804001323200_dgae376-B18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.omtn.2018.05.002","article-title":"Circulating miRNAs as predictive biomarkers of type 2 diabetes Mellitus development in coronary heart disease patients from the CORDIOPREV study","volume":"12","author":"Jimenez-Lucena","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"2024111804001323200_dgae376-B19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","article-title":"Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Comparative study randomized controlled trial research support, non-U.S. Gov't","volume":"107","author":"Zampetaki","year":"2010","journal-title":"Circ Res"},{"issue":"8","key":"2024111804001323200_dgae376-B20","doi-asserted-by":"crossref","first-page":"e3384","DOI":"10.1210\/clinem\/dgac254","article-title":"Deterioration of glycemic control in youth-onset type 2 diabetes: what are the early and late predictors?","volume":"107","author":"Zeitler","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024111804001323200_dgae376-B21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/dc23-1540","article-title":"Plasma miRNAs and treatment failure in participants in the treatment options for type 2 diabetes in adolescents and youth (TODAY) study","volume":"47","author":"Wander","year":"2024","journal-title":"Diabetes Care"},{"issue":"5","key":"2024111804001323200_dgae376-B22","doi-asserted-by":"crossref","first-page":"e0155108","DOI":"10.1371\/journal.pone.0155108","article-title":"MicroRNA-194 modulates glucose metabolism and its skeletal muscle expression is reduced in diabetes","volume":"11","author":"Latouche","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"2024111804001323200_dgae376-B23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3892\/etm.2022.11589","article-title":"Relationship of miRNA\u2013126 and miRNA\u2013122 expression with type 2 diabetes mellitus and related glucose metabolism parameters: a systematic review and meta\u2013analysis","volume":"24","author":"He","year":"2022","journal-title":"Exp Ther Med"},{"issue":"6","key":"2024111804001323200_dgae376-B24","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41556-022-00919-7","article-title":"Cancer-cell-secreted extracellular vesicles suppress insulin secretion through miR-122 to impair systemic glucose homeostasis and contribute to tumour growth","volume":"24","author":"Cao","year":"2022","journal-title":"Nat Cell Biol"},{"key":"2024111804001323200_dgae376-B25","doi-asserted-by":"crossref","first-page":"5525112","DOI":"10.1155\/2021\/5525112","article-title":"MiR-122 participates in oxidative stress and apoptosis in STZ-induced pancreatic beta cells by regulating PI3K\/AKT signaling pathway","volume":"2021","author":"Wang","year":"2021","journal-title":"Int J Endocrinol"},{"issue":"5","key":"2024111804001323200_dgae376-B26","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.3390\/nu7053483","article-title":"MiRNA-194 regulates palmitic acid-induced toll-like receptor 4 inflammatory responses in THP-1 cells","volume":"7","author":"Tian","year":"2015","journal-title":"Nutrients"},{"issue":"8","key":"2024111804001323200_dgae376-B27","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/db16-1405","article-title":"Protective effect of let-7 miRNA family in regulating inflammation in diabetes-associated atherosclerosis","volume":"66","author":"Brennan","year":"2017","journal-title":"Diabetes"},{"issue":"5","key":"2024111804001323200_dgae376-B28","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jid.2017.11.038","article-title":"Staphylococcus aureus triggers induction of miR-15B-5P to diminish DNA repair and deregulate inflammatory response in diabetic foot ulcers","volume":"138","author":"Ramirez","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2024111804001323200_dgae376-B29","doi-asserted-by":"crossref","first-page":"101685","DOI":"10.1016\/j.trim.2022.101685","article-title":"CircPTTG1IP knockdown suppresses rheumatoid arthritis progression by targeting miR-431-5p\/FSTL1 axis","volume":"75","author":"Yang","year":"2022","journal-title":"Transpl Immunol"},{"issue":"1","key":"2024111804001323200_dgae376-B30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13287-018-0980-4","article-title":"miR-431 inhibits adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via targeting insulin receptor substance 2","volume":"9","author":"Wang","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"2024111804001323200_dgae376-B31","doi-asserted-by":"crossref","first-page":"105975","DOI":"10.1016\/j.biocel.2021.105975","article-title":"MicroRNA-431-5p encapsulated in serum extracellular vesicles as a biomarker for proliferative diabetic retinopathy","volume":"135","author":"Yu","year":"2021","journal-title":"Int J Biochem Cell Biol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae376\/58184891\/dgae376.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/12\/3027\/60680279\/dgae376.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/12\/3027\/60680279\/dgae376.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T04:00:35Z","timestamp":1731902435000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/12\/3027\/7685428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,5,30]]},"published-print":{"date-parts":[[2024,11,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae376","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,5,30]]}}}